Please assess the completion status of the following clinical trial:

Trial Title: Comparison of Training Load With/Out Blood Flow Restriction Training in Rheumatoid Populations

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: None
- Number of Arms: 3.0

Eligibility Criteria:
Inclusion Criteria:~* diagnosis from LSUHSC-SHreveport Rheumatologist of rheumatoid arthritis (RA), osteoarthritis (OA), or myositis~* stable medication for at least 3 months~* OA in weightbearing joints, and limited to non-advanced OA per Kellgren Lawrence grading~* cleared by rheumatologist for participation in high intensity training and blood flow restriction training~Exclusion Criteria:~* cardiovascular or other disease preventing exercise participation~* within past 6 months, have performed regular physical activity training or physical therapy~* one or more arthroplasty in weight-bearing joints~* taking more then 5mg of prednisone in past 3 months~* unable to perform timed up and go test, 10 meter walk test, or 6 minute walk test without more than supervision assistance; assistive devices can be used

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 85 Years
- Healthy Volunteers: f

Study Arms:
- Traditional High-Intensity Training (Type: EXPERIMENTAL): Participants will perform their training at \~70% of their 1-repetition maximum, as traditionally advocated in strengthening literature. Each of the diagnoses (RA, OA, myositis) will have a High-Intensity arm.
- Low Intensity plus Blood Flow Restriction Training (Type: EXPERIMENTAL): Participants will perform their training at \~30% of their 1-repetition maximum, and will have blood flow partially occluded (60-70%) to the training limb. Each of the diagnoses (RA, OA, myositis) will have a Low-Intensity plus Blood Flow Restriction arm.
- Control (Type: NO_INTERVENTION): Each of the diagnoses (RA, OA, myositis) will have a control arm. The control groups will be evaluated at time 0, 4 weeks, and 8 weeks but will not receive intervention.

Based on this trial design, predict the completion outcome and termination type (if applicable).